Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02007356 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

Study acronym: CCS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv17
  2. Enrollment target: 12 to 30
    • Primary and study completion dates: Dec 2022 to Dec 2026
    v16
  3. 2 versions Re-verified since Feb 1, 2021, no change to tracked fieldsv14-v15
  4. Primary and study completion dates: Dec 2020 to Dec 2022v13
  5. Primary and study completion dates: Dec 2019 to Dec 2020v12
Show 10 earlier versionsHide 10 earlier versions
  1. Re-verified, no change to tracked fieldsv11
  2. Enrollment target: 6 to 12
    • Primary and study completion dates: Nov 2018 to Dec 2019
    v10
  3. Primary and study completion dates: Nov 2017 to Nov 2018v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary and study completion dates: Nov 2016 to Nov 2017v7
  6. Re-verified, no change to tracked fieldsv6
  7. Primary and study completion dates: Nov 2015 to Nov 2016v5
  8. Re-verified, no change to tracked fieldsv4
  9. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Oct 2014 to Dec 2014
    • Site details revised
    v3
  10. Start date: Apr 2014 to Oct 2014
    • Study completion date: Nov 2015
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the feasibility of donor-derived interferon (IFN)-γ positive select-ed virus-specific T-cells using the cytokine capture system® (CCS) and the safety of subsequent infusion in recipients of hematopoietic stem cell transplantation (HSCT) with treatment refractory post-transplant viral infections. The CCS has already been successfully used in clinical studies in Germany and United Kingdom (UK).
Trial Details
NCT Number NCT02007356
Lead Sponsor University Hospital, Basel, Switzerland
Conditions
(from sponsor)		 Adenovirus Infection, EBV, Cytomegalovirus Infections, Cytokine Capture System, Allogenic Disease
Related terms Adenoviridae Infections, Cytomegalovirus Infections
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov